NLRP3 and liver disorder: It has been reported that treatment with antioxidants decreases ROS and consequently reduces NLRP3 inflammasome activation in a carbon tetrachloride-induced acute liver injury model [77,78], further supporting the relationship between ROS generation and NLRP3 activation in liver disease.